Evidence map›Paper›PMID 37145384›Full record

ReviewInternational microbiology : the official journal of the Spanish Society for Microbiology2023

Antimicrobial resistance and molecular epidemiology of carbapenem-resistant Escherichia coli from urinary tract infections in Shandong, China.

Ran Chen, Guili Wang, Qian Wang, Meng Zhang, Yueling Wang, Zhongkun Wan, Zaifeng Si, Yuanyuan Bai, Zhen Song, Xinglun Lu and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in International microbiology : the official journal of the Spanish Society for Microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Molecular characterization of uropathogenicJournal of veterinary science · 2025
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Ran Chen *Department of Clinical Laboratory, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250021, Shandong, China.
Guili Wang *Department of Clinical Laboratory, Beijing Xiao Tang Shan Hospital, Beijing, 102200, China.
Qian WangDepartment of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 9677# Jing-Shi Road, Jinan, 250014, People's Republic of China.
Meng ZhangDepartment of Clinical Laboratory, Liaocheng Second People's Hospital, Liaocheng, 252600, Shandong, China.
Yueling WangDepartment of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 9677# Jing-Shi Road, Jinan, 250014, People's Republic of China.
Zhongkun WanDepartment of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 9677# Jing-Shi Road, Jinan, 250014, People's Republic of China.
Zaifeng SiDepartment of Clinical Laboratory, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250021, Shandong, China.
Yuanyuan BaiDepartment of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 9677# Jing-Shi Road, Jinan, 250014, People's Republic of China.
Zhen SongDepartment of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 9677# Jing-Shi Road, Jinan, 250014, People's Republic of China.
Xinglun LuDepartment of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 9677# Jing-Shi Road, Jinan, 250014, People's Republic of China.
Yingying HaoDepartment of Clinical Laboratory, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250021, Shandong, China. haoyyjia@163.com.
Shandong First Medical University · CNShandong Provincial Hospital · CNLiaocheng People's Hospital · CNShandong University · CN

Funding

National Natural Science Foundation of China 81902119
6 · The paper itself

Abstract

objectivesUrinary tract infection (UTI) is one of the most common extraintestinal infections, and uropathogenic Escherichia coli (UPEC) is the main cause of UTIs. However, the ability to treat UTI has been compromised by the increase in antimicrobial resistance, especially carbapenem resistance. Here, we aimed to characterize the antimicrobial resistance and molecular epidemiology of carbapenem-resistant UPEC isolated in Shandong, China.

methodsIn total, 17 carbapenem-resistant UPEC (CR-UPEC) isolates were collected from July 2017 to May 2020 in the Shandong Provincial Hospital. Whole-genome sequencing and bioinformatics analyses were performed to understand the molecular epidemiology of CR-UPEC. Phylogenetic groups, drug resistance genes, biofilm formation, and virulence-related gene profiles of the isolates were analyzed. Plasmid profiling and conjugation assay were performed to evaluate the ability to transfer carbapenem resistance-related genes to other E. coli isolates. Biofilm formation was also evaluated, as it is important for the persistence of infectious diseases.

resultsWe observed that 15 out of 17 CR-UPEC strains were bla

conclusionsOur observations may assist in developing new therapeutic methods for drug-resistant organisms.

Indexed as

Escherichia coli InfectionsUrinary Tract InfectionsUropathogenic Escherichia coliAnti-Bacterial AgentsCarbapenemsDrug Resistance, BacterialHumansMolecular EpidemiologyPhylogenyAnti-Bacterial AgentsCarbapenemsAntimicrobial resistanceCarbapenem resistanceUrinary tract infectionUropathogenic Escherichia coli

Identifiers

PMID37145384
OpenAlexW4372298578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.